Yaming Su
Impact in
-
- HIV Research and Treatment
-
- Drug Transport and Resistance Mechanisms
Papers in ⓘ
-
- Cancer therapeutics and mechanisms 3
- RNA Interference and Gene Delivery 2
- Advanced biosensing and bioanalysis techniques 1
- Signaling Pathways in Disease 1
- Oncology 6
- Drug Transport and Resistance Mechanisms 5
- Co-authors
- Patrick J. Sinko (7 shared papers)Xiaoping Zhang (3 shared papers)Xiaorong Peng (1 shared paper)G. Miller Jonakait (1 shared paper)Doina Ganea (1 shared paper)Peidi Hu (1 shared paper)Anne Paccaly (1 shared paper)Christine Xu (1 shared paper)
- Journals
- Molecular Pharmaceutics (2 papers)Journal of Neuroimmunology (1 paper)Molecular Cancer Therapeutics (1 paper)Journal of Pharmacy & Pharmaceutical Sciences (1 paper)Cancer Letters (1 paper)
- Partner nations
- United StatesTaiwanSouth Korea
In The Last Decade
Yaming Su
11 papers receiving 302 citations
Peers
Comparison fields: 5 of 66
- Virology 28
- Oncology 143
- Infectious Diseases 64
- Pharmaceutical Science 19
- Pediatrics, Perinatology and Child Health 58
Countries citing papers authored by Yaming Su
This map shows the geographic impact of Yaming Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yaming Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yaming Su more than expected).
Fields of papers citing papers by Yaming Su
This network shows the impact of papers produced by Yaming Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yaming Su. The network helps show where Yaming Su may publish in the future.
Co-authors
The 25 scholars most cited alongside Yaming Su, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 91 | |
| 2 | 2006 | 53 | |
| 3 | 2003 | 31 | |
| 4 | 2007 | 30 | |
| 5 | 2019 | 29 | |
| 6 | 2004 | 28 | |
| 7 | 2006 | 25 | |
| 8 | 2007 | 10 | |
| 9 | 2004 | 5 | |
| 10 | 2018 | 2 | |
| 11 | 2011 | 2 |
About Yaming Su
Yaming Su is a scholar working on Molecular Biology, Oncology, Infectious Diseases, Pediatrics, Perinatology and Child Health and Surgery, having authored 11 papers that have together received 306 indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (5 papers), Cancer therapeutics and mechanisms (3 papers), RNA Interference and Gene Delivery (2 papers), HIV/AIDS drug development and treatment (2 papers), Advanced biosensing and bioanalysis techniques (1 paper), Lymphoma Diagnosis and Treatment (1 paper), Signaling Pathways in Disease (1 paper) and Pharmacological Effects and Toxicity Studies (1 paper). The work is most often cited by research in Virology (28 citations), Oncology (143 citations), Infectious Diseases (64 citations), Pharmaceutical Science (19 citations) and Pediatrics, Perinatology and Child Health (58 citations). Yaming Su has collaborated with scholars based in United States, Taiwan and South Korea. Frequent co-authors include Patrick J. Sinko, Xiaoping Zhang, Xiaorong Peng, G. Miller Jonakait, Doina Ganea, Peidi Hu, Anne Paccaly, Christine Xu, Li Wan and Carol R. Gardner. Their work appears in journals such as Molecular Pharmaceutics, Journal of Neuroimmunology, Molecular Cancer Therapeutics, Journal of Pharmacy & Pharmaceutical Sciences and Cancer Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.